Scribe Therapeutics
高管
查看带有其 14 名主要高管的组织结构图
Scribe Therapeutics 搜索最多的简介
- Benjamin Oakes, Chief Executive Officer and Director
- Behzad Aghazadeh, Director
- Vijay Pande, Director
高管在Scribe Therapeutics变化
- Maria Mirotsou已作为Vice President of Discovery Biology加入公司 (新闻发布的2023十二月21号).
- Aarif Khakoo已作为Chief Scientific Officer and Head of Research and Development加入公司 (新闻发布的2023十二月21号).
创建提醒
跟踪 Scribe Therapeutics 的高管变动
生物技术
Scribe Therapeutics 拥有 2,282 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Scribe Therapeutics 的最新新闻稿
- Press Release – Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting • Scribe
- Press Release – Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • Scribe
- Press Release – Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target • Scribe
- Press Release – Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Scribe
- Press Release – Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology • Scribe
- A decade later, biotech’s CRISPR revolution is still going strong
- Press Release – Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases • Scribe
- Press Release – Scribe Therapeutics Announces Oral Presentation at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting • Scribe
- Press Release – Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days • Scribe
- Building a biotech in a downturn: 3 lessons from VCs and startup CEOs
- View more press releases Close
通过电子邮件
